Cover Image

Faster IgG4 Depletion Kinetics Observed for Anti-Desmoglein 3 Autoantibodies Following Rituximab Treatment in Patients with Pemphigus Vulgaris

Abstract is missing (Short communication)

Saved in:

Bibliographic Details
Main Authors:	Katharina Boch (Author), Ewan A. Langan (Author), Nina van Beek (Author), Khalaf Kridin (Author), Enno Schmidt (Author), Detlef Zillikens (Author), Ralf J. Ludwig (Author), Christoph M. Hammers (Author), Katja Bieber (Author)
Format:	Book
Published:	Medical Journals Sweden, 2022-12-01T00:00:00Z.
Subjects:	article
Online Access:	Connect to this object online.
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Sustained CD19+CD27+ Memory B Cell Depletion after Rituximab Treatment in Patients with Pemphigus Vulgaris
by: Katharina Boch, et al.
Published: (2022)

Autoantibodies other than anti-desmogleins in pemphigus vulgaris patients
by: Marwah Adly Saleh, et al.
Published: (2017)

Long-lasting localized pemphigus vulgaris without detectable serum autoantibodies against desmoglein 3 and desmoglein 1
by: Asuka Yoshifuku, et al.
Published: (2016)

Evaluation of desmoglein 1 and desmoglein 3 autoantibodies in oral cancer: A pilot study
by: Pavan Kumar Yellarthi, et al.
Published: (2023)

Targeted Immunotherapy with Rituximab Leads to a Transient Alteration of the IgG Autoantibody Profile in Pemphigus Vulgaris
by: Ralf Müller, et al.
Published: (2010)

Epidemiology of Pemphigus
by: Khalaf Kridin, et al.
Published: (2021)

Squamous cell carcinoma of the soft palate associated with autoantibodies to desmoglein 1 and 3
by: Yoshifumi Maumi, et al.
Published: (2013)

Oral lichen planus with low-titer autoantibodies to BP180 and desmoglein 3
by: Miki Sato, et al.
Published: (2024)

Survival of Adjuvant Drugs for Treatment of Pemphigus: A Population-based Cohort Study
by: Khalaf Kridin, et al.
Published: (2021)

Is Rituximab-Associated Hypogammaglobulinemia Always Linked to B-Cell Depletion?
by: Anthie Damianaki, et al.
Published: (2022)

Bullous pemphigoid associated with milia, increased serum IgE, autoantibodies against desmogleins, and refractory treatment in a young patient
by: Shu Ding, et al.
Published: (2017)

B-cell depletion and primary Sjögren's syndrome: is there a role for rituximab?
by: P. Sarzi-Puttini, et al.
Published: (2011)

Short-term clinical and serological follow-up with conventional and conformational anti-desmoglein antibodies in treatment-naïve and previously treated patients with pemphigus vulgaris after receiving rituximab
by: Hoorieh Alaeen, MD, et al.
Published: (2019)

Immunomodulator Galectin-9 is Increased in Blood and Skin of Patients with Bullous Pemphigoid
by: Jasper Pruessmann, et al.
Published: (2021)

IgA pemphigus showing IgA antibodies to desmoglein 1 and 3
by: Salama Hegazy, et al.
Published: (2016)

Factors associated with non-pathogenic antibodies against desmoglein-3 in pemphigus foliaceus
by: Sebastian Vernal, et al.
Published: (2024)

A Retrospective Analysis of Rituximab Treatment for B Cell Depletion in Different Pediatric Indications
by: Merlin Wennmann, et al.
Published: (2021)

Diagnostic Value and Practicability of Serration Pattern Analysis by Direct Immunofluorescence Microscopy in Pemphigoid Diseases
by: Maike M. Holtsche, et al.
Published: (2021)

A Case of Adenomyosis with a High Titer of IgG Autoantibody to Calreticulin
by: Neil M. Gude BSc, MSc, PhD, et al.
Published: (2013)

Desmoglein-1 Deficiency Mimicking Omenn Syndrome
by: Meltem Comert, et al.
Published: (2024)

Evaluation of the possible association between acantholysis and anti‐desmogleins 1 and 3 values in pemphigus vulgaris and pemphigus foliaceus
by: Maryam Mobarakabadi, et al.
Published: (2019)

Association between IgG4 Autoantibody and Complement Abnormalities in Systemic Lupus Erythematosus
by: Qingjun Pan, et al.
Published: (2016)

Oxidative stress in patients with endemic pemphigus foliaceus and healthy subjects with anti-desmoglein 1 antibodies
by: Ericson Leonardo Gutierrez, et al.
Published: (2018)

Increased Risk of Pemphigus among Patients with Psoriasis: A Large-scale Cohort Study
by: Khalaf Kridin, et al.
Published: (2020)

Targeting IgG Autoantibodies for Improved Cytotoxicity of Bactericidal Permeability Increasing Protein in Cystic Fibrosis
by: Karen McQuillan, et al.
Published: (2020)

Pemphigus Vulgaris and Pemphigus Foliaceus: Differences in Epidemiology and Mortality
by: Khalaf Kridin, et al.
Published: (2017)

Usefulness of desmoglein 1 and 3 in serodiagnosis of pemphigus vulgaris and its correlation with disease activity - ELISA study
by: Neha Gandhi, et al.
Published: (2014)

Evaluation of the Diagnostic Value of Oesophageal Biopsies for Direct Immunofluorescence Microscopy in Mucous Membrane Pemphigoid
by: Kaan Yilmaz, et al.
Published: (2023)

Ring‐shaped plaque on the face
by: Stella Riemann, et al.
Published: (2023)

Differential Downregulation of E-Cadherin and Desmoglein by Epidermal Growth Factor
by: Miquella G. Chavez, et al.
Published: (2012)

Immunization of BALB/c mice with pigeon IgY induces the production of anti-IgG autoantibodies
by: Ivan Sammir Aranda-Uribe, et al.
Published: (2017)

The Faster Forward Fund
by: Michael Scriven
Published: (2011)

Acantholysis may precede elevation of circulating anti‐desmoglein 3 antibody levels in pemphigus vulgaris presenting with desquamative gingivitis
by: Hiroyasu Endo, et al.
Published: (2019)

Desmoglein 4 Mutation Underlies Autosomal Recessive Keratosis Pilaris Atrophicans
by: Eran Cohen-Barak, et al.
Published: (2018)

Mutations of Desmoglein-2 in Sudden unexplained death in the chinese han population
by: Junyi Lin, et al.
Published: (2019)

Unexpected and persistent depletion of B lymphocytes CD20 following a minimum dose of anti-CD20 antibody (Rituximab)
by: V. Bruzzese, et al.
Published: (2011)

Immunologic overlap in a case of linear IgG/IgA bullous dermatosis responsive to rituximab
by: Dmitry Nedosekin, PhD, et al.
Published: (2021)

Pediatric pemphigus herpetiformis treated with rituximab
by: Mira Hamed, MD, et al.
Published: (2024)

Which start is faster in finswimming?
by: Vasileios Stavrou, et al.
Published: (2018)

Accessible diagnostic methods to differentiate between epidermolysis bullosa acquisita and other subepidermal autoimmune bullous diseases
by: Khalaf Kridin
Published: (2018)